Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 100%

All‐cause mortality D28 · people with mild/moderate/severe/critical COVID‐19

Tociliuzumab leads to lower all‐cause mortality D28 compared with standard care/placebo (high certainty).

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
RR 0.88 [0.81, 0.94]
18 studies · 7428 participants
High